Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases

被引:0
|
作者
Leandro Marcelo Martinez
Valeria Beatriz Fernández Vallone
Vivian Labovsky
Hosoon Choi
Erica Leonor Hofer
Leonardo Feldman
Raúl Horacio Bordenave
Emilio Batagelj
Federico Dimase
Ana Rodriguez Villafañe
Norma Alejandra Chasseing
机构
[1] National Council of Scientific and Technical Research (CONICET),Immunohematology Laboratory, Experimental Biology and Medicine Institute (IBYME)
[2] Institute for Regenerative Medicine at Scott & White,Texas A&M Health Science Center, College of Medicine
[3] Favaloro Fundation,Department of Bone Marrow Transplantation
[4] Iriarte Hospital,Department of Oncology
[5] Central Militar Hospital,Department of Oncology
[6] Central Militar Hospital,Department of Hemotherapy
[7] Central Militar Hospital,Department of Diagnosis and Treatment
来源
关键词
Breast cancer; Bone marrow; Pre-metastatic niche; Mesenchymal stem cells; Bone metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Bone metastasis is an incurable complication of breast cancer affecting 70–80 % of advanced patients. It is a multistep process that includes tumour cell mobilisation, intravasation, survival in the circulation, extravasation, migration and proliferation in the bone marrow/bone. Although novel findings demonstrate the bone marrow microenvironment significance in bone metastatic progression, a majority of studies have focused on end-stage disease and little is known about how the pre-metastatic niche arises in the bone marrow/bone tissues. We demonstrated a significant increase in patients’ peripheral blood plasma ability to induce transendothelial migration of MCF-7 cells compared with healthy volunteers. Moreover, high RANKL, MIF and OPG levels in patients’ peripheral blood could play a role in the intravasation, angiogenesis, survival and epithelial–mesenchymal transition of circulating tumour cells. Also, we observed a significant increase in patients’ bone marrow plasma capacity to induce transendothelial migration of MDA-MB231 and MCF-7 cells compared with healthy volunteers. Furthermore, patients’ bone marrow mesenchymal stem cells could control the recruitment of tumour cells, modifying the MCF-7 and MDA-MB231 cell migration. In addition, we found a significantly higher MDA-MB231 cell proliferation when we used patients’ bone marrow plasma compared with healthy volunteers. Interestingly, PDGF-AB, ICAM-1 and VCAM-1 levels in patients’ bone marrow were significantly higher than the values of healthy volunteers, suggesting that they could be involved in the cancer cell extravasation, bone resorption and cancer cell proliferation. We believe that these results can reveal new information about what alterations happen in the bone marrow of advanced breast cancer patients before bone colonisation, changes that create optimal soil for the metastatic cascade progression.
引用
收藏
页码:213 / 232
页数:19
相关论文
共 50 条
  • [1] Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
    Marcelo Martinez, Leandro
    Fernandez Vallone, Valeria Beatriz
    Labovsky, Vivian
    Choi, Hosoon
    Leonor Hofer, Erica
    Feldman, Leonardo
    Horacio Bordenave, Raul
    Batagelj, Emilio
    Dimase, Federico
    Rodriguez Villafane, Ana
    Alejandra Chasseing, Norma
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (02) : 213 - 232
  • [2] Osteoclastogenesis process in bone marrow of untreated advanced breast cancer patients
    Fernandez Vallone, Valeria Beatriz
    Choi, Hooson
    Martinez, Leandro
    Labovsky, Vivian
    Batagelj, Emilio
    Dimase, Federico
    Feldman, Leonardo
    Bordenave, Moracio
    Alejandra Chasseing, Norma
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 221 - 221
  • [3] CYTOKERATIN POSITIVITY IN BONE MARROW CELLS AS PREDICTOR OF ONSET OF BONE METASTASES IN PATIENTS WITH ADVANCED BREAST CANCER
    Loriggiola, Laura
    Lumachi, Franco
    Marino, Filippo
    Chiara, Giordano Bruno
    Basso, Stefano Maria Massimiliano
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S241 - S241
  • [4] Bone marrow metastases in breast cancer
    Pikarsky, E
    Peretz, T
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08): : 577 - 578
  • [5] Treatment of Bone Metastases in Patients with Advanced Breast Cancer
    Gnant, Michael
    Balic, Marija
    Petru, Edgar
    Raunik, Wolfgang
    Singer, Christian F.
    Steger, Guenther G.
    Watzke, Ingeborg M.
    Brodowicz, Thomas
    BREAST CARE, 2012, 7 (02) : 92 - 98
  • [6] Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis
    Fernandez Vallone, Valeria B.
    Hofer, Erica L.
    Choi, Hosoon
    Bordenave, Raul H.
    Batagelj, Emilio
    Feldman, Leonardo
    La Russa, Vincent
    Caramutti, Daniela
    Dimase, Federico
    Labovsky, Vivian
    Martinez, Leandro M.
    Chasseing, Norma A.
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (03) : 317 - 332
  • [7] Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis
    Valeria B. Fernández Vallone
    Erica L. Hofer
    Hosoon Choi
    Raúl H. Bordenave
    Emilio Batagelj
    Leonardo Feldman
    Vincent La Russa
    Daniela Caramutti
    Federico Dimase
    Vivian Labovsky
    Leandro M. Martínez
    Norma A. Chasseing
    Clinical & Experimental Metastasis, 2013, 30 : 317 - 332
  • [8] CLINICAL SYMPTOMS OF BONE MARROW METASTASES IN BREAST CANCER PATIENTS
    Rodionov, Valery
    Bogomolova, Oksana
    Rodionova, Maria
    BREAST, 2011, 20 : S41 - S41
  • [9] Incidence of mammaglobin positive tumor cells in peripheral blood and bone marrow from breast cancer patients
    Zach, Otto
    Kessler, Barbara
    Kasparu, Hedwig
    Girschikofsky, Michael
    Krieger, Otto
    Hauser, Hanns
    Koenig, Josef
    Machherndi-Spandi, Sigrid
    Fuegger, Reinhold
    Lutz, Dieter
    ANNALS OF ONCOLOGY, 2004, 15 : 16 - 16
  • [10] Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer
    Bischoff, J
    Rosenberg, R
    Dahm, M
    Janni, W
    Gutschow, K
    MOLECULAR STAGING OF CANCER, 2003, 162 : 135 - 140